Week of February 13, 2023 |
|
Short Blog, High Hopes
Greetings on Saturday night. Tomorrow evening is the Super Bowl, between the Philadelphia Eagles and Kansas City Chiefs.
|
|
Research Explores a Next-Gen Blood Screening to Find Multiple Cancer Types Earlier
Collaborative research about to begin at MedStar Washington Hospital Center (MWHC) will study the clinical application of a blood test called Galleri, which can provide early detection of many types of cancer — some of which have no routine screenings. Researchers involved in the MWHC arm of the clinical trial, which is being conducted at sites nationwide, include Georgetown Lombardi affiliate member and MWHC Medical Director of Cancer Services Christopher Gallagher, MD. Read more about this study.
|
|
Abstract Deadline Extended: MedStar Health-Georgetown University Research & Education Symposium
The abstract deadline for the MedStar Health-Georgetown University Research & Education Symposium has been extended to this Friday, February 17. See the symposium website for abstract submission guidelines and portal. The symposium will be held on Monday, May 8 at the Bethesda North Marriott Hotel and Conference Center. Contact research@medstar.net with questions.
|
|
Center for Healthy Aging Symposium Abstracts Due February 28
Abstracts are being accepted for the Second Annual Georgetown Center for Healthy Aging Symposium, “Advancing Knowledge About Aging to Improve Health and Health Care,” which takes place July 12. The symposium, held in-person and online, will include posters, oral presentations and panel discussions on special topics such as new research collaborations, career development, community outreach and grant proposal development. Upload abstracts via this Google Form. Contact Bill Rebeck, PhD, or Pamela Saunders, PhD, with questions.
|
|
Be Inspired to Join BellRinger 2023!
BellRinger 2023 registration is underway, and already more than 100 people have signed up to ride. Watch this video to be inspired to join them. Sign up at the newly redesigned BellRinger website.
|
|
Shared Resources Spotlight |
|
This weekly series showcases Georgetown University’s Shared Resources, which provide Georgetown Lombardi researchers with access to state-of-the-art equipment and technical expertise to support their work. |
|
Tissue Culture & Biobanking Shared Resource
The Tissue Culture & Biobanking Shared Resource (TCBSR) provides Georgetown Lombardi investigators with all tissue culture-related aspects of their work and offers unique services that enable the biobanking of blood and other biofluid specimens obtained from subjects enrolled in various Georgetown Lombardi studies. The TCBSR offers high-quality tissue culture reagents and infrastructure, as well as access to well-annotated, high-quality biofluid specimens through a meticulously maintained biorepository. Tissue culture services include cell culture and cell banking; conditional reprogramming of cells to establish primary epithelial cell cultures from normal and cancer tissues; providing a safe and secure cryostorage facility for frozen stocks of cancer cell lines and other reagents; operating three separate shared tissue culture laboratories; and providing training in the basic principles of tissue culture with hands-on experience. Biobanking services include the processing of specimens (e.g., preparing aliquots of serum), banking the specimens, and disbursing as needed.
|
|
Monday, February 13
2:00 - 3:00 p.m.
Presented by Peter Nemes, PhD, associate professor, Department of Chemistry & Biochemistry, University of Maryland, College Park. Join this presentation via Zoom.
|
|
Cancer Cell Biology Program Meeting
Monday, February 13
4:00 - 5:00 p.m.
|
|
CDI Seminar: “HPV-Associated Cancer Disparities: Lessons from a Community Based Intervention in Four Large and Diverse Cities”
Tuesday, February 14
3:00 - 4:00 p.m.
Presented by Abraham Aragones, MD, assistant attending/assistant professor, Immigrant Health and Cancer Disparities Service, Memorial Sloan-Kettering Cancer Center. Join via Zoom.
|
|
Faculty and Staff Headshot Session
Wednesday, February 15
11:00 a.m. - 1:00 p.m.
Riggs Library, Healy Hall
|
|
Wednesday, February 15
12:00 - 1:00 PM
Learn about ORCID, short for Open Researcher and Contributor ID, why you need one, and how GUFaculty360 now connects and syncs with it. Presented by Dahlgren Memorial Library. Register for this Zoom workshop.
|
|
Thursday, February 16
3:00 - 4:00 p.m.
Presented by Matthew Lockett, PhD, associate professor, Department of Chemistry, University of North Carolina at Chapel Hill. Join this seminar in Regents Hall 109.
|
|
Thursday, February 16
4:00 - 5:00 p.m.
Presented by Ezra Burstein, MD, PhD, professor, internal medicine & molecular biology, division chief, Digestive and Liver Diseases, UT Southwestern Medical Center. Join this seminar in the New Research Building Auditorium and via Zoom.
|
|
Friday, February 17
12:00 - 1:00 p.m.
Presented by Yuan Zhu, PhD, professor, Department of Pediatrics, George Washington University School of Medicine and Gilbert Family Endowed Professor of Neurofibromatosis Research and scientific director in the Gilbert Family Neurofibromatosis Institute, Children’s National Hospital. Join this lecture via Zoom.
|
|
Funding and Award Opportunities |
|
NEW Children’s Cancer Foundation 2023 Call for Proposals
The Children's Cancer Foundation, Inc. (CCF) invites individuals from Maryland, D.C. and Northern Virginia conducting research and/or programs relevant to pediatric cancer to submit proposals for grant award consideration. CCF will be awarding multiple one-year grants for research; one one-year grant for research by a young investigator (Giant Food NextGen Award); and several one-year grants for support of an existing or new program that serves the pediatric cancer community. Applications must be submitted via email or file transfer service to Rose Ann Verrilli: rverrilli@childrenscancerfoundation.org no later than May 7 at 11:59 p.m. ET. Review and download application materials and guidelines.
|
|
Cancer Screening Research Network Funding Opportunities
The National Cancer Institute Division of Cancer Prevention has released three funding opportunity announcements for applications to create the Cancer Screening Research Network (CSRN). The CSRN will conduct rigorous, multi-center cancer screening trials and studies to evaluate emerging technologies and strategies for the purpose of cancer screening. The CSRN will have three different components for an integrated network.
View the following links for more information about each funding opportunity:
-
RFA-CA-23-020: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
-
RFA-CA-23-021: Statistics and Data Management Center (UG1 Clinical Trial Required)
-
RFA-CA-23-022: Coordinating and Communication Center (UG1 Clinical Trial Required)
Application deadline: February 28, at 5 p.m.
|
|
Request for Applications: Aging & Cancer Research with The Israel Cancer Research Fund
The Samuel Waxman Cancer Research Foundation and The Israel Cancer Research Fund are accepting applications for collaborative proposals to focus on aging and cancer. Projects must involve collaboration between two research groups — one in the U.S. and one in Israel — with different, but complementary expertise. Proposals must justify the partnership through synergistic scientific aims. Two collaborative projects will be funded. Each of these projects will be awarded $200,000 per year for two years, or a total of $400,000, with each research group receiving $100,000 per year ($200,000 total). Successful projects may be eligible for a third year of funding at the level of $100,000 ($50,000 per research group). View full RFA guidelines. Submit letters of intent via email by 5 p.m. ET, March 1 to Wylie Tene at wtene@waxmancancer.org.
|
|
BRCA Research and Education (CureBRCA) Grants
BRCA Research & Cure Alliance (CureBRCA) is now accepting funding applications for BRCA-related initiatives that involve prevention, detection, screening, and/or treatment for men at risk for BRCA-related cancers. All grant applications must address one of the following: identification of at-risk carriers, cancer prevention, early detection and screening for cancer, or novel treatment approaches pertaining to BRCA-related cancers. BRCA research, educational initiatives, or outreach efforts that cater to men who are at risk for BRCA mutations are desired. Applications that include collaboration, either across institutions, or within a single institution will be prioritized. Applications submitted from junior faculty or from underrepresented groups are encouraged. Applicants can request up to $500,000. View RFA for more information about eligibility, funding, evaluation, key dates, and application portal. Application deadline: March 1.
|
|
AAI Careers in Immunology Fellowship Program
The AAI Careers in Immunology Fellowship Program supports the career development of young scientists by providing eligible PIs with one year of salary support for a trainee in their labs. The fellowship does not pay fringe benefits or other indirect costs to the institution. PIs must be independent research scientists who are AAI regular members in good standing. At the time of application, the PI should have no more than $350,000 U.S. dollars in total annual direct costs (excluding PI salary) from all funding sources, including start-up funds. Trainees must be AAI members in good standing at the time of application and have a current Trainee Certification Form on record with AAI. AAI encourages applications from and for women and underrepresented minority scientists. Award consideration is based on the merit of the PI’s proposed project, potential of the trainee, the quality of the training environment, and financial need. View application instructions. Deadline: March 15, at 11:59 p.m. ET.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | Hematology Board Review | Podium A / Zoom
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 81202; phone: 202-796-7323)
12:15 PM | Protocol Writing Series - Dr. Weinberg | Podium A / Zoom
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom (dial 646-558-8656; Meeting ID: 941 1630 5835)
|
|
9:00 AM | Cancer Research Data Meeting | Speaker: Erin Scheidemann | W302 New Research Building or Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | Journal Club – Drs. Kessler and Tiu | Podium A / Zoom
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series: “Investigating MEK Inhibition and Resistance in the Treatment of Nervous System Tumors” | Yuan Zhu, PhD | Zoom
12:00 PM | No Lecture | Zoom
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
